# ZYNYZ
> **BLA761334** · Biologics License Application · Sponsor: INCYTE CORP · Approved 2023-03-22
## Drug
- **FDA Application Number:** BLA761334
- **Application type:** Biologics License Application
- **Brand name:** ZYNYZ
- **Generic name:** RETIFANLIMAB-DLWR
- **Active ingredients:** RETIFANLIMAB-DLWR
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** INCYTE CORP
- **Manufacturer:** Incyte Corporation
- **First approval:** 2023-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761334)
---
*AI Analytics · CC0 1.0*